Published on Medical Design Technology (http://www.mdtmag.com)

Home > Funding: InSightec closes $30.9 million Series C round

Funding: InSightec closes $30.9 million Series C round

Mass Device

InSightec completes $30.9 million Series C financing round, led by GE Healthcare and other investors. Lands CE Marked approval for its ExAblate Neuro in the treatment of Parkinson's disease.

InSightec picked off $30.9 million in a Series C financing round, led by a $27.6 million investment from GE Healthcare and $3.3 million by other investors, the company said.

In addition, the Israeli-based ultrasound maker also named VP & general manager of the MRI business James Davis as new CEO and Tom Gentile as chairman of board. Gentile most recently was
president & CEO of GE Healthcare.

Source URL (retrieved on 06/19/2013 - 3:16am): http://www.mdtmag.com/news/2012/12/funding-insightec-closes-309-million-series-c-round?qt-recent_content=0